Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Filings indexed 558 across all filing types
Latest filing 2022-03-08 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司关于调整第二届董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the composition of the company's board committees, specifically the appointment of a new independent director and adjustments to the audit, nomination, and remuneration committees. It includes details about the members and their roles. There is no financial data, no mention of a report or meeting results, and it is not a regulatory filing or certification. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2022-03-08 Chinese
北京诺禾致源科技股份有限公司2021年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2021年度业绩快报公告" which translates to "2021 Annual Performance Express Report Announcement." It contains preliminary financial data and key financial metrics for the year 2021, including revenue, profit, net assets, and earnings per share. The document explicitly states that the data is preliminary, unaudited, and that the final audited data will be in the company's 2021 Annual Report. The length of the document is 2360 characters, which is relatively short and consistent with a brief earnings summary rather than a full annual report. The document is an initial announcement of yearly financial results with key highlights, not the full detailed report. Therefore, it fits the definition of an Earnings Release (ER). FY 2021
2022-02-24 Chinese
北京诺禾致源科技股份有限公司2022年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2022 First Extraordinary General Meeting" of Beijing Novogene Technology Co., Ltd. It contains detailed instructions for the meeting, agenda items, voting procedures, and a specific proposal to elect a new independent director. The content is procedural and preparatory for a shareholder meeting rather than a report of financial results or an announcement of voting results. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or remuneration report. The document is clearly the meeting materials provided to shareholders for the Extraordinary General Meeting (EGM). Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings. The document length is under 5,000 characters but contains substantive meeting materials, not just an announcement of a report publication, so it is not RPA or RNS.
2022-02-22 Chinese
诺禾致源:独立董事候选人声明
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Beijing Nuohua Zhiyuan Technology Co., Ltd. It details the candidate's qualifications, independence, and compliance with relevant laws and regulations. There is no financial data, no report or announcement of financial results, no meeting materials, no voting results, and no mention of any report publication. The document is a statement related to board/management information, specifically about the nomination and qualifications of an independent director candidate. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on the candidate's declaration, not a report or announcement of a report.
2022-02-20 Chinese
北京诺禾致源科技股份有限公司关于补选独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of an independent director to the company's board. It details the resignation of a previous independent director, the nomination of a new candidate, and the candidate's qualifications and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting presentation or voting results. This fits the category of Board/Management Information, as it concerns changes in the company's board of directors.
2022-02-20 Chinese
北京诺禾致源科技股份有限公司关于召开2022年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2022 first extraordinary general meeting of shareholders (临时股东大会) for Beijing Novogene Technology Co., Ltd. It details the meeting date, voting methods, agenda items (such as election of an independent director), registration procedures, and proxy authorization form. It does not contain financial statements or results, nor is it a transcript or presentation. It is a formal announcement of a shareholders meeting, not the meeting materials or results themselves. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is about 3,041 characters, consistent with a detailed meeting notice and proxy form. Therefore, the classification is PSI with high confidence.
2022-02-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.